BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma.
Ontology highlight
ABSTRACT: Despite advances in therapy, glioblastoma remains an incurable disease with a dismal prognosis. Recent studies have implicated cancer stem cells within glioblastoma (glioma stem cells, GSCs) as mediators of therapeutic resistance and tumor progression. In this study, we investigated the role of the transforming growth factor-β (TGF-β) superfamily, which has been found to play an integral role in the maintenance of stem cell homeostasis within multiple stem cell systems, as a mediator of stem-like cells in glioblastoma. We find that BMP and TGF-β signaling define divergent molecular and functional identities in glioblastoma, and mark relatively quiescent and proliferative GSCs, respectively. Treatment of GSCs with BMP inhibits cell proliferation, but does not abrogate their stem-ness, as me
SUBMITTER: Sachdeva R
PROVIDER: S-EPMC6787003 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA